Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10,290 GBX | -0.04% | -1.53% | -2.92% |
Mar. 18 | Sector Update: Health Care Stocks Edge Up Late Monday Afternoon | MT |
Mar. 18 | Sector Update: Health Care Stocks Rise Monday Afternoon | MT |
Financials (USD)
Sales 2024 * | 51.01B | Sales 2025 * | 54.59B | Capitalization | 203B |
---|---|---|---|---|---|
Net income 2024 * | 8.98B | Net income 2025 * | 10.26B | EV / Sales 2024 * | 4.34 x |
Net Debt 2024 * | 18.42B | Net Debt 2025 * | 12.07B | EV / Sales 2025 * | 3.94 x |
P/E ratio 2024 * |
23
x | P/E ratio 2025 * |
20.1
x | Employees | 89,900 |
Yield 2024 * |
2.37% | Yield 2025 * |
2.48% | Free-Float | 96.46% |
Latest transcript on AstraZeneca PLC
1 day | -0.04% | ||
1 week | -1.53% | ||
Current month | +3.08% | ||
1 month | +1.94% | ||
3 months | -0.64% | ||
6 months | -4.08% | ||
Current year | -2.92% |
Managers | Title | Age | Since |
---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 63 | 12-09-30 |
Aradhana Sarin
DFI | Director of Finance/CFO | 50 | 21-07-31 |
Cindy Hoots
CTO | Chief Tech/Sci/R&D Officer | 56 | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sherilyn McCoy
BRD | Director/Board Member | 65 | 17-09-30 |
Ahmed Hamdy
PRN | Corporate Officer/Principal | 59 | 13-01-31 |
Philip Broadley
BRD | Director/Board Member | 63 | 17-04-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
9.20% | 11 M€ | +0.83% | - | |
5.39% | 196 M€ | +10.20% | ||
5.17% | 18 M€ | +4.89% | - | |
4.89% | 770 M€ | +4.40% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 10,290 | -0.04% | 3,782,068 |
24-03-15 | 10,294 | -1.04% | 5,253,583 |
24-03-14 | 10,402 | -0.54% | 2,846,633 |
24-03-13 | 10,458 | +0.21% | 4,183,232 |
24-03-12 | 10,436 | -0.13% | 3,246,478 |
Delayed Quote London S.E., March 18, 2024 at 12:35 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.92% | 203B | |
+30.83% | 679B | |
+30.96% | 589B | |
+0.01% | 381B | |
+15.18% | 314B | |
+11.39% | 308B | |
+0.78% | 212B | |
-6.09% | 210B | |
-3.72% | 158B | |
-5.94% | 144B |